• 2 February 2018

    Qiagen to buy Spain’s STAT-Dx for $147m

    Netherlands-based molecular testing firm Qiagen has signed an agreement to acquire all shares of Spanish diagnostics maker STAT-Dx for a cash consideration of around $147m.

  • 31 January 2018

    Varian Medical to purchase Sirtex for $1.28bn

    US-based Varian Medical Systems has entered an agreement to purchase all outstanding shares of Australian life sciences firm Sirtex Medical for about A$1.58bn ($1.28bn).